Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | NTRK1 | P04629 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 11/20 | 0.38 |
| ▸ | CA2 | P00918 | 11/20 | 0.38 |
| ▸ | CA12 | O43570 | 7/20 | 0.38 |
| ▸ | CA9 | Q16790 | 7/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 5/20 | 0.36 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18355014 | 0.87 | KDM4E (0.41) | MEN1KMT2ASMN1; SMN2CA1CA2 | |
| SCHEMBL18360553 | 0.80 | CA1 (0.53) | CA1CA2CA12CA9KDM1A | |
| SCHEMBL18354113 | 0.77 | LMNA (0.46) | KMT2ACA1CA2CA12CA9 | |
| SCHEMBL18355019 | 0.76 | LMNA (0.45) | SMN1; SMN2 | |
| SCHEMBL18355007 | 0.76 | RORC (0.48) | SMN1; SMN2CA1CA2CA12CA9 | |
| SCHEMBL18354112 | 0.74 | KMT2A (0.48) | MEN1KMT2ASMN1; SMN2CA1CA2 | |
| SCHEMBL18355006 | 0.74 | CYP1A2 (0.50) | MEN1KMT2ACA1CA2CA12 | |
| SCHEMBL18354762 | 0.73 | CA1 (0.50) | CA1CA2CA12CA9CA4 | |
| SCHEMBL18360528 | 0.73 | KMT2A (0.49) | MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL17927740 | 0.72 | PDE4B (0.49) | CA1CA2CA12CA9CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170000133-A1 | BENZOXABOROLE FUNGICIDES | SYNGENTA PARTICIPATIONS AG (SE) | 2017-01-05 | — | — | US | disclosed |
| US-20170000133-A1 | BENZOXABOROLE FUNGICIDES | SYNGENTA PARTICIPATIONS AG (SE) | 2017-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170000133-A1 | BENZOXABOROLE FUNGICIDES | CYP4X1, BROX, CYP1B1 | MEN1 2465/4885KMT2A 2550/4885SMN1; SMN2 2375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.